FDA NDC Directory · JSON-LD · Markdown

Mirabegron

NDC 67877-890 · HUMAN PRESCRIPTION DRUG · FOR SUSPENSION, EXTENDED RELEASE

Labeler / ManufacturerAscend Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA219323
Dosage form / routeFOR SUSPENSION, EXTENDED RELEASE · ORAL
Active ingredientsMIRABEGRON (8 mg/mL)
Marketing started20260615
Package count1

External sources

Source: openFDA. Public-domain (CC0).